AbbVie buys Pharmacyclics in a deal for 21 billion USD

Noam Stiekema

AbbVie buys Pharmacyclics in a deal for 21 billion USD. The company surpassed the offer of rival Johnson & Johnson to control revolutionary therapy of cancer of the blood that will enable it to develop in the field of oncology. Under the deal, the American producer of rare medicines AbbVie will pay 261.25 USD per […]

AbbVie

AbbVieAbbVie buys Pharmacyclics in a deal for 21 billion USD. The company surpassed the offer of rival Johnson & Johnson to control revolutionary therapy of cancer of the blood that will enable it to develop in the field of oncology. Under the deal, the American producer of rare medicines AbbVie will pay 261.25 USD per share in cash and new shares of AbbVie, announced in a statement the two companies on Thursday. The price was 39% above the closing price of the shares of Pharmacyclics Inc from 24th February 2015, the day before announcing the possibility of the deal.

Acquisitions will help AbbVie to reduce its dependence on Humira, best-selling product is the company’s treatment of arthritis. Now it will be able to expand in the field of cancer therapy, one of the most promising areas of development of pharmaceuticals. AbbVie will gain control over Imbruvica, easy to use pill that costs about 100 thousand dollars a year and helps to avoid some serious side effects of chemotherapy. It has already been approved for the four different types of leukemia.

Pharmacyclics led negotiations and almost had agreed to be acquired by Johnson & Johnson. The discussed price was 250 USD per share, but AbbVie made better offer at the last minute, said a source familiar with the situation. AbbVie expects about 58% of the transaction to be paid in cash and 42% – equity, and be completed by mid-year. Its shares rose 1.1 percent to 60.27 dollars a share in New York. Since separated from Abbott Laboratories in 2013, AbbVie had not been able to finish any of тхе мега-деалс that tempt most of the drug industry.

Read this next

Market News

Stock Market Analysis: Is NVDA Losing Its Leadership?

Since the beginning of the week, the S&P 500 Index (US500) has seen a modest increase of about 0.58%, whereas NVDA’s share price has experienced a decline of approximately 3.8%. This recent divergence raises concerns among Nvidia stock investors — could it signify a loss of NVDA’s market leadership?

Industry News

ESG: Australian regulator wins first greenwashing court case against Vanguard

Vanguard admitted that a notable portion of the securities within both the Index and the Fund did not undergo the promised ESG scrutiny.

Fintech, Uncategorized

BitMEX integrates HALO from Solidus Labs for cross-market surveillance

““The recent approval of the Spot Bitcoin ETF has piqued the market’s interest. As a result of price volatility, the trading volumes for crypto derivatives have gone up substantially. HALO, with its advanced technology and crypto-native detection architecture, will enable BitMEX to smoothly and safely scale trade surveillance across its increased trading volumes and provide the necessary safeguards for new product launches.”

Reviews

IUX Broker Review

IUX, recently rebranded from IUX Markets, stands as a multi-asset Forex broker recognized for its regulatory compliance across various jurisdictions.

Industry News

Horizon Software rebrands to Horizon Trading Solutions

“Horizon Trading Solutions has seen accelerated global growth over the past year to meet the rising demand for our trading solutions and built-for-purpose technology offering. The choice to rebrand represents a key part of this development, while maintaining our heritage and history in the industry.”

Market News

USDJPY has surged to levels last witnessed in 2022. Should we consider opening a short position?

The recent resurgence of the US dollar has propelled USD/JPY to new heights, touching levels not seen since 2022. This surge comes against the backdrop of stable short-term yields and ongoing economic data that fails to signal a significant slowdown, prompting questions about the extent of current monetary easing measures.

Digital Assets

DED Trends on Twitter After Memecoin Snapshot Announcement

Polkadot-backed community coin #DED, made it to the trending charts on X, demonstrating community’s engagement and interest behind the memecoin. 

Digital Assets

BlockDAG Presale Nears $10 Million Amid Toncoin’s Momentum, Green Bitcoin’s Presale, and the Rise of Other Top Cryptos

This article will examine three top trending topics: Toncoin’s potential, Green Bitcoin’s innovative presale, and BlockDAG’s sustainable mining approach. These cryptocurrencies take centre stage for their uniqueness and innovation.

Digital Assets

Coinbase scores minor victory vs SEC, but lawsuit to proceed

A federal judge in Manhattan, U.S. District Judge Katherine Polk Failla, ruled on Wednesday that the U.S. Securities and Exchange Commission’s (SEC) lawsuit against Coinbase can largely proceed.

<